Teligent
TLGT
#10339
Rank
HK$0.12 B
Marketcap
HK$1.33
Share price
-13.85%
Change (1 day)
1,612.20%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -HK$0.35 Billion

According to Teligent's latest financial reports the company's current earnings are HK$46.29 Million. In 2020 the company made an earning of -HK$0.31 Billion a decrease over its 2019 earnings that were of -HK$62.86 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-HK$0.35 Billion13.35%
2020-HK$0.31 Billion378.89%
2019-HK$62.86 Million-46.87%
2018-HK$0.12 Billion10.47%
2017-HK$0.11 Billion-637.49%
2016HK$19.92 M-179.64%
2015-HK$25.02 Million-181.72%
2014HK$30.61 M-4806.02%
2013-HK$0.66 Million-97.35%
2012-HK$24.58 Million6.23%
2011-HK$23.14 Million-18.59%
2010-HK$28.42 Million-11.37%
2009-HK$32.07 Million98.4%
2008-HK$16.17 Million156.15%
2007-HK$6.31 Million-59.36%
2006-HK$15.53 Million17.92%
2005-HK$13.17 Million37.7%
2004-HK$9.57 Million25.51%
2003-HK$7.62 Million-289.84%
2002HK$4.01 M-1605.88%
2001-HK$0.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.25 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA